Skip to main content

Currently Skimming:

Appendix C: Presentations and Visits
Pages 181-183

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 181...
... Roberts, Tyco Health Care/Mallinckrodt • The Security Imperative of Eliminating Commercial Use of HEU, Ed S Lyman, Union of Concerned Scientists • Cost of Converting from HEU to LEU Targets for Medical Radioisotope Production, Frank von Hippel, Princeton University • IAEA Input to NAS Study on Medical Radioisotope Production without HEU, Ira Goldman, International Atomic Energy Agency (IAEA)
From page 182...
... Production to LEU Target Technology, Grant Malkoske, MDS Nordion • Mallinckrodt's Mo-99 Process & Progress to LEU Conversion, Dale Simpson, Tyco Healthcare/Mallinckrodt • Ion Beam Applications: Past, Present, and Future, Henri Bonet, Institute National des Radioéléments (IRE) Washington, D.C., June 11–12, 2007 • Global Threat Reduction Initiative–Reactor Conversion Program– Molybdenum-99 Production with LEU, Parrish Staples, DOE-NNSA • Drug Master File Development and FDA Filings for LEU-Produced Medical Radionuclides, Roy Brown, CORAR • Cardinal Health Nuclear Pharmacy Services, Jack Coffey, Cardinal Health • The Cost of Developing Imaging Agents for Routine Clinical Use, Adrian Nunn, Bracco Research • Status of IAEA Mo-99 Activities, Ira Goldman, IAEA • National Academy of Sciences: Medical Isotope Production Study, Ralph Butler, University of Missouri Research Reactor (MURR)
From page 183...
... Butler, MURR • Efforts by Current Commercial Mo-99 Producers to Examine LEU Technologies, Roy W Brown, CORAR Site Visits • August 20–21, 2007: Visit to AECL Chalk River Laboratories (Chalk River, Ontario, Canada)


This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More information on Chapter Skim is available.